Substance / Medication

Eflornithine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Barber-Say syndrome and Ablepharon-Macrostomia syndrome: An overview.
De Maria Beatrice, Mazzanti Laura, Roche Nathalie et al. · Am J Med Genet A · 2016
PMID: 27196381Meta-Analysis
Laser and photoepilation for unwanted hair growth.
Haedersdal M, Gøtzsche P C · Cochrane Database Syst Rev · 2006
PMID: 17054211Meta-Analysis
Hypertrichosis in females applying minoxidil topical solution and in normal controls.
Dawber R P R, Rundegren J · J Eur Acad Dermatol Venereol · 2003
PMID: 12702063Meta-Analysis
Eyelash growth from application of bimatoprost in gel suspension to the base of the eyelashes.
Wester Sara Tullis, Lee Wendy W, Shi Wei · Ophthalmology · 2010
PMID: 20163864RCTFull text (PMC)
Use of Eflornithine Hydrochloride Cream to Reduce Facial Hair Growth in Flapped Skin.
Valejo Coelho Margarida Moura, Carvalho Rodrigo · Dermatol Surg · 2019
PMID: 30608291Case Report
Eflornithine Hydrochloride.
Am J Health Syst Pharm · 2024
PMID: 38478924Other
Eflornithine Hydrochloride-Loaded Electrospun Nanofibers as a Potential Face Mask for Hirsutism Application.
Almuwallad Shuruq S, Alzahrani Dunia A, Aburayan Walaa S et al. · Pharmaceutics · 2023
PMID: 37765309OtherFull text (PMC)
Spectrophotometric estimation of eflornithine hydrochloride by using ion-pair reagents.
Kumar Amit, Singh Vijender, Kumar Praveen · Pak J Pharm Sci · 2015
PMID: 25730793Other
A method to improve the efficacy of topical eflornithine hydrochloride cream.
Kumar Amit, Naguib Youssef W, Shi Yan-Chun et al. · Drug Deliv · 2016
PMID: 25182303PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Eflornithine hydrochloride (substance)
SNOMED CT
108716007
UMLS CUI
C0282042

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.